Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Elevra Lithium ( (AU:ELV) ) has provided an announcement.
Elevra Lithium has signed a non-binding memorandum of understanding to potentially supply up to 144,000 tonnes per year of spodumene concentrate from 2028 to Mangrove Lithium, a Canadian lithium converter. The initial five-year arrangement, which could cover about 46% of Elevra’s projected sales volumes, would be priced at market-related levels within a floor and ceiling band to support more stable cash flows across price cycles.
Mangrove plans to process the concentrate in Eastern Canada into battery-grade lithium hydroxide, leveraging its electrochemical refining technology and Québec’s low-cost, low-carbon power. The prospective partnership is positioned to cut freight costs, create one of the shortest mine-to-chemicals supply chains in the sector, support potential brownfield expansion at North American Lithium, and strengthen Canada and Québec’s domestic battery and critical minerals ecosystem.
The most recent analyst rating on (AU:ELV) stock is a Hold with a A$6.00 price target. To see the full list of analyst forecasts on Elevra Lithium stock, see the AU:ELV Stock Forecast page.
More about Elevra Lithium
Elevra Lithium is a North American lithium producer listed on the ASX and Nasdaq, focused on supplying spodumene concentrate from its North American Lithium operation. The company targets the growing battery materials market, particularly electric vehicle and energy storage supply chains in Canada and beyond.
YTD Price Performance: -20.15%
Average Trading Volume: 1,281,607
Technical Sentiment Signal: Hold
Current Market Cap: A$1.08B
For detailed information about ELV stock, go to TipRanks’ Stock Analysis page.